Literature DB >> 11391171

Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil.

A L Bittencourt1, I Dourado, P B Filho, M Santos, E Valadão, L C Alcantara, B Galvão-Castro.   

Abstract

An evaluation of human T-cell lymphotropic virus type 1 (HTLV-1) infection among 6754 pregnant women in Salvador, Bahia, Brazil using enzyme-linked immunosorbent assay, Western blot analysis, and polymerase chain reaction assay found a rate of infection of 0.84% (57 of 6754 women). Epidemiologic and obstetric data on the HTLV-1-positive pregnant women were analyzed and compared with data on a control group of HTLV-1-negative pregnant women. The mean age of the HTLV-1-positive women was 26.2 years. All were seronegative for HIV and syphilis, and only 2 reported a past history of sexually transmitted infection and more than 10 sexual partners. Of the HTLV-1-positive women, 88.5% were breast-fed, 4% were bottle fed, and 7.5% did not know. Six women had received blood transfusions, and only 1 reported intravenous drug use. Fifty-two HTLV-1-positive women could be followed: 45 had full-term deliveries, 5 had premature deliveries, and 2 had abortions. Our results indicate that (1) the frequency of HTLV-1 infection among pregnant women is relatively high in Salvador, Bahia, Brazil; (2) maternal infection was probably acquired more frequently through breast-feeding, but the sexual route was certainly the second most important means of transmission; (3) HTLV-1-positive women had a history of eczema-like infections in childhood more frequently than the control group; (4) HTLV-1 infection did not interfere in the course of pregnancy; and (5) no associated congenital infections were observed in the HTLV-1-positive women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391171     DOI: 10.1097/00126334-200104150-00016

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  16 in total

1.  High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru.

Authors:  Jorge O Alarcón; Heidi B Friedman; Silvia M Montano; Joseph R Zunt; King K Holmes; Gerald V Quinnan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

2.  Molecular detection of human T cell lymphotropic virus type 1 in pregnant women from Maranhão state, Brazil.

Authors:  Maria de Fátima Castro Mendes; José de Ribamar Oliveira Lima; Bruna de Oliveira de Melo; Conceição de Maria Fernandes da Silva Pinto; Hermerson Sousa Maia; Thiago Azevedo Feitosa Ferro; Silvio Gomes Monteiro; Edel Figueiredo Barbosa Stancioli; Maria Rosa Quaresma Bomfim
Journal:  Braz J Microbiol       Date:  2020-01-28       Impact factor: 2.476

3.  Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Ana Verena Galvão-Castro; Aidê Nunes; Ana Karina Galvão-Barroso; Thessika Hialla Almeida Araújo; Regina Helena Rathsam-Pinheiro; Ceuci Lima Xavier Nunes; Adriele Ribeiro; Monique Lírio; Noilson Lázaro Gonçalves; Sônia Lúcia Rangel; Cristiane Maria Carvalho Costa Dias; Daniele Piai Ozores; Selena Márcia Dubois-Mendes; Isabela Lima; André Luís Pereira Silva; Washington Luiz Abreu de Jesus; Fred Luciano Neves Santos; José Guilherme Reis de Oliveira; Yscela Vanessa Pimentel de Moraes; Adijeane Oliveira de Jesus; Francisco Daltro; Ney Boa-Sorte; Humberto Castro-Lima; Maria Luísa Carvalho Soliani
Journal:  Front Med (Lausanne)       Date:  2022-06-07

Review 4.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

5.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

6.  Prevalence of HTLV-1/2 in pregnant women living in the metropolitan area of Rio de Janeiro.

Authors:  Denise Leite Maia Monteiro; Stella Regina Taquette; Danielle Bittencourt Sodré Barmpas; Nádia Cristina P Rodrigues; Sérgio A M Teixeira; Lucia Helena C Villela; Márcio Neves Bóia; Alexandre José Baptista Trajano
Journal:  PLoS Negl Trop Dis       Date:  2014-09-04

7.  HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil.

Authors:  David Nunes; Ney Boa-Sorte; Maria Fernanda Rios Grassi; Graham P Taylor; Maria Gloria Teixeira; Mauricio L Barreto; Inês Dourado; Bernardo Galvão-Castro
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

8.  Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Authors:  Maria Fernanda Rios Grassi; Normeide Pedreira Dos Santos; Monique Lírio; Afrânio Lineu Kritski; Maria da Conceição Chagas Almeida; Leonardo Pereira Santana; Noilson Lázaro; Juarez Dias; Eduardo Martins Netto; Bernardo Galvão-Castro
Journal:  BMC Infect Dis       Date:  2016-09-19       Impact factor: 3.090

9.  High prevalence of human T-lymphotropic virus infection in indigenous women from the peruvian Amazon.

Authors:  Magaly M Blas; Isaac E Alva; Patricia J García; Cesar Cárcamo; Silvia M Montano; Nicanor Mori; Ricardo Muñante; Joseph R Zunt
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  HTLV-1 in pregnant women from the Southern Bahia, Brazil: a neglected condition despite the high prevalence.

Authors:  Marco Antônio Gomes Mello; Aline Ferreira da Conceição; Sandra Mara Bispo Sousa; Luiz Carlos Alcântara; Lauro Juliano Marin; Mônica Regina da Silva Raiol; Ney Boa-Sorte; Lucas Pereira Souza Santos; Maria da Conceição Chagas de Almeida; Tâmara Coutinho Galvão; Raquel Gois Bastos; Noilson Lázaro; Bernardo Galvão-Castro; Sandra Rocha Gadelha
Journal:  Virol J       Date:  2014-02-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.